8-K - Esperion Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Management Change

Regulation Fd

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment o

Management Change

$535.0K$35.0K

7.01

by reference. The information in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” fo

Regulation Fd

9.01

. Financial Statements and Exhibits. Exhibit No. Description 10.1 Employment Agreement, effective as of November 17, 2025, by and between Esperion Therapeutics,

Exhibits Only

Source Document

Exhibits (3)

10.1

EX-10.1

8-K

99.1

EX-99.1